Ignite Creation Date:
2024-05-06 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05277571
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2022-03-03
Brief Title:
A Single-ascending Dose Part A and Repeat-dose Part B Study to Investigate the Safety Pharmacokinetics and Efficacy Part B Only of UCB1381 in Healthy Study Participants Part A and in Study Participants With Moderate to Severe Atopic Dermatitis Part B
Sponsor:
Organization:
UCB Pharma